Keywords
Epidemiologic Studies
; Signs and Symptoms
Intensive Care Units
How to Cite
Abstract
The objective was to describe the characteristics of patients admitted to a private hospital in Belo Horizonte with a positive diagnosis for COVID-19 in categories of gender, age, symptoms, ICU passage, need for mechanical ventilation and outcome. Retrospective epidemiological study was conducted in a large private hospital in Belo Horizonte with 3,034 patients diagnosed with COVID-19 between March 2020 and December 2021. Variables: gender, age, symptoms, need for intensive care, mechanical ventilation, and mortality. Descriptive analysis used media for numerical data and absolute and relative frequencies for categorical variables. The most common symptoms in hospitalized patients with COVID-19 included cough, myalgia, headache, fever, coryza, odynophagia, dyspnea, and diarrhea. The less common symptoms were found in 17.5% of the patients studied. Cough was the most prevalent symptom among patients in the hospital analyzed, while other studies reported fever, dyspnea, and tachycardia as the most common symptoms. The need for ICU admission and use of mechanical ventilation was lower in the studied hospital compared to other studies, and the mean age of patients was also lower. Limitations include the lack of information on comorbidities and the accounting of deaths only after ICU stay.
References
1. Souza ASR, Amorim MMR, Melo ASO, Delgado AM, Florêncio ACMCC, Oliveira TV et al. General aspects of the COVID-19 pandemic. Rev Bras Saúde Mater Infant. 2021;21(Supl. 1):529-64. https://doi.org/10.1590/1806-9304202100S100003
2. Fundação Oswaldo Cruz – Fiocruz. Boletim Observatório Covid-19. Um balanço da pandemia em 2020. Rio de Janeiro, 2020. 16 p. Edição especial. [acesso 2023 Nov 23]. Disponível em: https://www.arca.fiocruz.br/handle/icict/45793
3. Fundação Oswaldo Cruz – Fiocruz. Boletim Observatório Covid-19. Boletim Covid - Balanço de 2 anos da pandemia. Rio de Janeiro, 2022. 29 p. [acesso 2023 Nov 23]. Disponível em: https://portal.fiocruz.br/documento/boletim-covid-balanco-de-2-anos-da-pandemia
4. Mcintosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): Clinical features. UpToDate. Filadélfia: Wolters Kluwer Health, 2020a. [acesso em 2023 nov 23]. Disponível em: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-clinical-features
5. Marin BG, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):e2146. https://doi.org/10.1002/rmv.2146
6. Zampieri FG, Soares M, Borges LP, Salluh JIF, Ranzani OT. Epimed Monitor ICU Database®: um registro nacional baseado na nuvem, para pacientes adultos internados em unidades de terapia intensiva do Brasil. Rev Bras Ter Intensiva. 2017;29(4):418-26. https://doi.org/10.5935/0103-507X.20170062
7. Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y et al. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021;11(6):e047007. https://doi.org/10.1136/bmjopen-2020-047007
8. Martimbianco ALC, Pacheco RL, Bagattini AM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. https://doi.org/10.1111/ijcp.14357
9. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MG et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev. 2022;5:CD013665. https://doi.org/10.1002/14651858.CD013665.pub3
10. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-59. https://doi.org/10.1001/jama.2020.6775
11. Firpo AS, Scuffi J, Buzzo J, Alarcia V, Ferrari A, Vittal N et al. Perfil clínico-epidemiológico de pacientes internados con COVID-19 en Coronel Suárez, Argentina. Medicina. 2022;82(5):684-8. Disponível em: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802022000900684&lng=es
12. Mylona E, Evangelia M, Eleftheria K, Vasilios V, Vana S, Vissaria S et al. Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region. Pathog Glob Health. 2021;115(4):243-9. https://doi.org/10.1080/20477724.2021.1893485
13. Ghaebi M, Tahmasebi S, Jozghorbani M, Sadeghi A, Thangavelu L, Zekiy AO et al. Risk factors for adverse outcomes of COVID-19 patients: possible basis for diverse responses to the novel coronavirus SARS-CoV-2. Life Sci. 2021;277:119503. https://doi.org/10.1016/j.lfs.2021.119503
14. Jang SY, Seon JY, Eun BL, Koh SB, Yoo JH, Lee WY et al. Risk factors of outcomes of COVID-19 patients in Korea: focus on early symptoms. J Korean Med Sci. 2021;36(18):e132. https://doi.org/10.3346/jkms.2021.36.e132
15. Candido DS, Claro IM, Jesus JG, Souza WM, Moreira FRR, Dellicour S et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020;369(6508):1255-60. https://doi.org/10.1126/science.abd2161
16. Tardif JC, Cossette M, Guertin MC, Bouabdallaoui N, Dubé MP, Boivin G et al. Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19. Int J Infect Dis. 2022;116:387-90. https://doi.org/10.1016/j.ijid.2022.01.020
17. Lobo AP, Cardoso-dos-Santos AC, Rocha MS, Pinheiro RS, Bremm JM, Macário EM et al. COVID-19 epidemic in Brazil: where are we at? Int J Infect Dis. 2020;97:382-5. https://doi.org/10.1016/j.ijid.2020.06.044
18. Ministério da Saúde (Brasil). COVID19. Painel Coronavírus. [acesso 2022 Nov 28]. Disponível em: https://covid.saude.gov.br
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Leonardo Meira de Faria, Maria Clara Miranda Lino, Pedro Henrique Andrade Benício , Laís Campolina Almeida, Deborah dos Reis Estrella, Bruno Porto Pessoa, Amanda Damasceno de Souza